Artia Global Partners »

Revolution Medicines shares owned by Artia Global Partners

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 96k 45.35

More positions owned by Artia Global Partners

Eli Lilly & Co. (LLY)
Novo-nordisk A S Adr (NVO)
Viking Therapeutics (VKTX)
Intra Cellular Therapies (ITCI)
Astrazeneca Sponsored Adr (AZN)
Soleno Therapeutics (SLNO)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Vaxcyte (PCVX)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
Neurocrine Biosciences (NBIX)
Revolution Medicines (RVMD)
Dyne Therapeutics (DYN)

View all positions for Artia Global Partners

Top funds holding Revolution Medicines

Vanguard Group
BlackRock
BlackRock
Farallon Capital Management
Baker Bros. Advisors
Nextech Invest
Paradigm Biocapital Advisors
T. Rowe Price Associates
State Street Corporation
Bellevue Group
Henderson Group
Boxer Capital
Alphabet
Jpmorgan Chase & Co
Casdin Capital

View all funds holding Revolution Medicines